ArticlePloS one2019

Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces amyloid-β burden in a mouse model of Alzheimer's disease.

Deborah A Roby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.